Table 4 One-Way ANOVA of CSA-AKI after robotic cardiac surgery

Age, years

47.84 ± 11.53

41.19 ± 13.10

Male, n(%)

21(56.76)

34(31.19)

Height, cm

161.57 ± 7.79

160.77 ± 7.72

Weight, kg

61.35 ± 11.89

57.30 ± 11.13

BMI, kg/m²

23.42 ± 3.78

22.13 ± 3.61

BSA, m²

1.62 ± 0.18

1.56 ± 0.17

Diabetes, n(%)

2(5.41)

1(0.91)

Hypertension, n(%)

8(21.62)

10(9.17)

Smoking, n(%)

13(35.13)

15(13.76)

Alcohol consumption, n(%)

15(40.54)

12(11.01)

NYHA

 I, n(%)

0(0)

2(1.83)

 II, n(%)

18(48.65)

77(70.64)

 III, n(%)

19(51.35)

30(27.52)

LVFS, %

36.49 ± 4.59

36.53 ± 4.71

LVEF, %

66.38 ± 5.21

66.28 ± 6.52

LAD, mm

37.51 ± 7.32

34.28 ± 6.54

LVDs, mm

43.78 ± 6.70

42.51 ± 6.97

RAD, mm

36.95 ± 6.72

37.88 ± 7.91

RVDs, mm

26.27 ± 6.42

28.11 ± 8.84

Tricuspid valve gradient, mmHg

29.24 ± 11.22

26.26 ± 12.38

SPAP, mmHg

37.32 ± 13.17

35.34 ± 15.50

Operative time ≥ 300 min, n(%)

29(78.38)

47(43.12)

CPB time, min

181.01 ± 89.36

123.49 ± 74.08

Cross-clamp time, min

112.32 ± 70.27

69.58 ± 56.04

TC, mmol/L

3.96 ± 1.09

3.92 ± 0.93

TG, mmol/L

1.62 ± 1.13

1.15 ± 0.71

LDL, mmol/L

2.44 ± 0.71

2.37 ± 0.64

HDL, mmol/L

1.11 ± 0.33

1.26 ± 0.40

ALT, U/L

24.63 ± 17.04

19.40 ± 11.71

AST, U/L

23.41 ± 10.31

22.63 ± 7.79

TBIL, µmol/L

13.76 ± 6.22

14.25 ± 7.22

DBIL, µmol/L

2.91 ± 2.38

2.77 ± 1.71

ALB, g/L

41.25 ± 3.82

41.44 ± 4.19

PA, mg/L

232.66 ± 64.99

224.62 ± 42.93

SCr, µmol/L

65.79 ± 17.11

60.82 ± 13.28

GFR, %

142.79 ± 45.02

144.94 ± 34.86

UA, µmol/L

340.92 ± 76.86

322.29 ± 92.65

HGB, g/L

136.65 ± 16.47

136.67 ± 25.66

PLT, 10⁹/L

222.62 ± 56.52

226.47 ± 67.92